Literature DB >> 8708024

Intermittent fluconazole dosing in patients with onychomycosis: results of a pilot study.

R R Assaf1, B E Elewski.   

Abstract

BACKGROUND: Therapeutic limitations of griseofulvin in treating onychomycosis have led to a search for alternative antimycotic agents. An optimal dosing regimen for fluconazole has yet to be defined.
OBJECTIVE: Our purpose was to evaluate the intermittent use of fluconazole (either once-weekly or alternate-day dosing) without concurrent nail avulsion in patients with moderate to severe onychomycosis.
METHODS: Eleven patients with mycologically confirmed onychomycosis of the toenails or fingernails (43 infected nails) were treated with intermittent fluconazole until clinical cure was obtained. Eight patients received fluconazole 300 mg once weekly, one patient received 200 mg once weekly, and two patients received 100 or 200 mg of fluconazole every other day. Eight patients also used an adjunctive topical antimycotic preparation.
RESULTS: All six patients with toenails involved (32 infected nails) were clinically cured after a mean treatment duration of 6 months, and all five patients with fingernails involved (11 infected nails) were cured after 3.7 months. There were no significant clinical or laboratory adverse events.
CONCLUSION: Intermittent fluconazole, taken once weekly or on alternate days, is a well-tolerated and efficacious method to treat onychomycosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8708024     DOI: 10.1016/s0190-9622(96)90327-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  7 in total

Review 1.  Onychomycosis: Practical Approaches to Minimize Relapse and Recurrence.

Authors:  Antonella Tosti; Boni E Elewski
Journal:  Skin Appendage Disord       Date:  2016-09-14

2.  Treatment of onychomycosis with efinaconazole 10% topical solution and quality of life.

Authors:  Antonella Tosti; Bom E Elewski
Journal:  J Clin Aesthet Dermatol       Date:  2014-11

Review 3.  Current and emerging azole antifungal agents.

Authors:  D J Sheehan; C A Hitchcock; C M Sibley
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

4.  Onychomycosis of Toenails and Post-hoc Analyses with Efinaconazole 10% Solution Once-daily Treatment: Impact of Disease Severity and Other Concomitant Associated Factors on Selection of Therapy and Therapeutic Outcomes.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2016-02

Review 5.  Updated Perspectives on the Diagnosis and Management of Onychomycosis.

Authors:  Julianne M Falotico; Shari R Lipner
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-15

Review 6.  Safety of fluconazole in paediatrics: a systematic review.

Authors:  Oluwaseun Egunsola; Abiodun Adefurin; Apostolos Fakis; Evelyne Jacqz-Aigrain; Imti Choonara; Helen Sammons
Journal:  Eur J Clin Pharmacol       Date:  2013-01-17       Impact factor: 2.953

7.  A comparative study to evaluate efficacy, safety and cost-effectiveness between Whitfield's ointment + oral fluconazole versus topical 1% butenafine in tinea infections of skin.

Authors:  Saket J Thaker; Dimple S Mehta; Hiral A Shah; Jayendra N Dave; Kunjan M Kikani
Journal:  Indian J Pharmacol       Date:  2013 Nov-Dec       Impact factor: 1.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.